Evaluation of cardiac arrhythmia in End Stage Renal Disease (ESRD) patient during hemodialysis

The evaluation of different dialysate potassium concentration on cardiac arrythmia during hemodialysis in End Stage Renal Disease (ESRD) patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201104206241N1

Enrollment

Registered

2012-01-08

Start date

2011-06-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Renal Disease. End Stage Renal Disease

Interventions

Intervention 1: Hemodialysis in control group with dialysate 2mmol/Eq. Intervention 2: Experimental group with dialysate 3mmol/Eq.

Treatment - Other

Hemodialysis in control group with dialysate 2mmol/Eq

Experimental group with dialysate 3mmol/Eq

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: All of ESRD patients who have started hemodialysis since two weeks ago. Exclusion criteria: a) old M.I with Q wave in ECG or acute M.I during hemodialysis; b) non sinusoidal rhythm and multiple PVC; c) with heart pace maker; d) the consumption of digital drug and chemotherapy medication in recently 2 weeks; e) heart EF<40% and severe heart valvular diseases in recently 3 months; f) non functional catheter or fistula or inadequate blood supply during hemodialysis.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Cardiac arrhythmias during hemodialysis. Timepoint: During hemodialysis. Method of measurement: Hultermonitoring.	—

Secondary

Measure	Time frame
Potassium. Timepoint: Bfore and After hemodialysis. Method of measurement: Blood sample.;Calcium. Timepoint: Bfore and After hemodialysis. Method of measurement: Blood sample.;PH of blood. Timepoint: Bfore and After hemodialysis. Method of measurement: Blood sample.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Masihollah Shakeri

Ahvaz University of Medical Sciences

dr_shakerim@yahoo.com+98 917 792 1924

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026